Background: Cardiovascular disease (CVD) remains the leading cause of mortality worldwide. Overweight, hypertension, and dyslipidemia are clinically recognized as the most significant cardiovascular risk conditions. Studies have shown that whole grains are beneficial to affect glucose metabolism, obesity, blood pressure, lipids and inflammatory markers. Methods: We did a research in PubMed, Embase and Cochrane for randomized controlled trials (RCTs) and selected the study according to the eligibility criteria and data extraction. Then we evaluate the effectiveness of whole grain foods on body weight (primary outcome) and other CVD risk factor indicators, including plasma low-density lipoprotein-cholesterol level, insulin resistance index, blood pressure, BMI, waist circumference (secondary outcome) in overweight/obese adults. Results: Our results showed that there are significant decrease of weight (P<0.0001, mean difference -0.5, 95% CI[-0.74, -0.25], I 2 =35%), LDL-C (P=0.05, mean difference -0.08, 95% CI[-0.16, 0.00], I 2 =27%), CRP (P<0.0001, mean difference -0.36, 95% CI[-0.54, -0.18], I 2 =69%) in whole grain group compared with control group (Fig 2-4). There are no significant difference in waist circumference (P=0.76, mean difference -0.12, 95% CI[-0.92,0.68], I 2 =44%), systolic blood pressure (P=0.88, mean difference -0.11, 95% CI[-1.55, 1.33], I 2 =3%), diastolic blood pressure (P=0.39, mean difference -0.44, 95% CI[-1.44, 0.57], I 2 =15%), fasting glucose (P=0.11, mean difference -0.05, 95% CI[-0.12, 0.01], I 2 =31%) between two groups. Conclusion: This study suggests whole grain food has only a moderate effect on reducing body weight, LDL-C and CRP in obese population, which is obviously showed in patients combined with other chronic metabolic disorders.